ResMed Unveils 2030 Strategy to Drive Growth, Profitability, and Shareholder Returns
September 30, 2024 16:05 ET
|
ResMed Inc.
2030 ambition to help more than 500 million people worldwide achieve their full health potentialShowcases integration of intelligent products and solutions within the ResMed ecosystem, designed to...
UPDATE -- ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep Health
September 30, 2024 09:48 ET
|
ResMed Inc.
ResMed Unveils New Collection of Digital and Personalized Solutions designed to
Improve Sleep Health
UPDATE -- ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health
September 30, 2024 09:23 ET
|
ResMed Inc.
ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health
ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health
September 30, 2024 08:10 ET
|
ResMed Inc.
ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health
ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep Health
September 30, 2024 08:01 ET
|
ResMed Inc.
ResMed Unveils New Collection of Digital and Personalized Solutions designed to
Improve Sleep Health
ResMed to Host Its 2024 Investor Day on September 30, 2024, at the New York Stock Exchange
September 10, 2024 16:05 ET
|
ResMed Inc.
Learn more about ResMed’s 2030 strategy to accelerate growthJoin in person or via virtual webcast SAN DIEGO, Sept. 10, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) will host an...
Vaping Expected to Increase COPD Health and Economic Burden by 2050
September 10, 2024 08:00 ET
|
ResMed Inc.
Vaping Expected to Increase COPD Health and Economic Burden by 2050
New ResMed-supported research presented at ERS 2024
ResMed Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference
August 28, 2024 16:05 ET
|
ResMed Inc.
SAN DIEGO, Aug. 28, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, Chairman and Chief Executive Officer, and Dr. Carlos Nunez, Chief Medical Officer, will...
ResMed Expands its Board of Directors and Appoints Healthcare Executive and Seasoned Finance Leader Christopher DelOrefice to its Board
August 15, 2024 16:05 ET
|
ResMed Inc.
DelOrefice is the Chief Financial Officer at BD, one of the largest global MedTech companies in the worldBoard appointment brings over 30 years of strategic and operational finance expertise SAN...
ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2024
August 01, 2024 16:05 ET
|
ResMed Inc.
Year-over-year revenue grows 9%, operating profit up 38%, non-GAAP operating profit up 30%Operating cash flow of $440 millionQuarterly dividend increases 10% to $0.53 per shareCompany to host an...